Deepinder Goyal, co-founder of Zomato, has indicated that the wearable device known as Temple may be available for purchase within the next year. He stated that the projected launch could occur in six to twelve months, although he acknowledged that the project has faced various delays. Goyal emphasised that he had been communicating about potential launch timelines for the last 18 months, creating uncertainty regarding the actual release date.

The anticipated cost of the Temple device is approximately $1,000, which translates to nearly Rs 1 lakh. This pricing has sparked discussion among potential customers, particularly as the product is being marketed primarily towards high-performance athletes. Goyal has made it clear, however, that the primary motivation behind the development of Temple was for personal use rather than mass-market appeal.

Reports suggest that Goyal has been seen wearing the device in public, with notable figures such as Badminton star PV Sindhu also seen using Temple during the 2026 Uber Cup in April. This visibility has generated a level of interest surrounding the device’s functionality, which Goyal describes as more advanced than traditional wearables.

Scientific Claims and Peer Reviews for Temple

The Temple device is intended to measure the body’s metabolic state in real time, a feature that differentiates it from other wearables primarily focused on tracking heart rates. Goyal provided insights into the reasoning behind this approach, indicating that while heart rate measurement was once considered a suitable indicator of metabolic activity, the Temple aims to offer a direct measurement of metabolism.

In a statement to Bloomberg, Goyal outlined his plans to substantiate the claims made about Temple through peer-reviewed studies. He stated that the device would be marketed as a wellness tool, and he is committed to providing empirical support for its health-related features. The anticipated studies are intended to include claims related to an innovative biomarker known as entropy, which Goyal’s team asserts is linked to metabolic functionality.

While the concept of entropy is central to Temple’s function, it is important to note that independent validation of this biomarker has yet to be completed. Goyal has also mentioned the potential for future medical approvals as additional features are developed for the device, showing an intent to adhere to regulatory processes.

Public Interest and Early Access Applications

In May 2026, Goyal announced the opening of early access applications for the Temple wearable, attracting significant public interest. Reports indicate that over 1 lakh individuals have submitted applications, competing for a limited first batch of 100 devices. This high level of engagement suggests a notable market demand for innovative health technology.

Goyal’s vision for Temple extends beyond personal use; he aims to create a product that contributes to the health and wellbeing of others, even if he initially began the project for his own needs. As the launch date approaches, the anticipation surrounding Temple will likely increase, especially as potential users await clarification on the device’s functionalities and scientific backing.

The future of Temple will depend on successful completion of peer reviews and regulatory approvals, as Goyal and his team continue to develop features that will enhance the device’s capabilities. Continued updates on the project may further shape public perception and interest in this innovative wearable technology.

Long or Short, get news the way you like. No ads. No redirections. Download Newspin and Stay Alert, The CSR Journal Mobile app, for fast, crisp, clean updates!

App Store –  https://apps.apple.com/in/app/newspin/id6746449540 

Google Play Store – https://play.google.com/store/apps/details?id=com.inventifweb.newspin&pcampaignid=web_share